T. Hadjieva

Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.

C. Grau, J. Overgaard, K. Dinshaw, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution

F. Tiberg, E. Cavallin-ståhl, T. Hadjieva, 2014, Supportive Care in Cancer.

Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey.

Vydmantas Atkocius, Peter Dunscombe, Yolande Lievens, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Indications for boost irradiation after quadrantectomy for early breast cancer

L. Marinova, T. Hadjieva, 2002 .

Endosonographic assessment of rectal cancer after neoadjuvant radiotherapy.

G. Stoilov, D. Kovatchki, L. Tankova, 2012, Medical ultrasonography.

Pattern of radiotherapy care in Bulgaria.

T. Hadjieva, 2015, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey.

Michael Baumann, Valentin Cernea, Vydmantas Atkocius, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Investigating micronucleus assay applicability for prediction of normal tissue intrinsic radiosensitivity in gynecological cancer patients.

E. Encheva, T. Hadjieva, R. Hristova, 2011, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.

T. Hadjieva, 1985, Radiobiologia, radiotherapia.

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer

M. Fassnacht, M. Schlumberger, G. Meinhardt, 2015, Endocrine-related cancer.

Safety and tolerability of sorafenib for treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC): Detailed analyses from the phase III DECISION trial.

M. Fassnacht, M. Schlumberger, C. Nutting, 2014 .